Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...

The story has been updated to correct the new site locations At a press conference in Washington, D.C., Eli Lilly And Co (NYSE:LLY) announced its plans to bolster its domestic medicine production ...

Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants ...

Eli Lilly said it plans to build three new plants in the United States to make the key ingredients used in pharmaceuticals, ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

Eli Lilly is doubling its U.S. manufacturing investment since 2020 as it seeks to produce more drugs domestically. Its latest ...

Eli Lilly plans to spend at least $27bn to build ... create more than 3,000 jobs for skilled workers like engineers and scientists as well as 10,000 construction jobs, the company said at a ...

Eli Lilly plans to invest at least $27 billion ... including engineers, scientists, operations personnel and lab technicians," along with nearly 10,000 construction jobs. Site locations are ...

Eli Lilly Chief Scientific Officer Dan Skovronsky said newer obesity medicines need to deliver more than just weight loss to compete with Zepbound and Wegovy. The development of pills and more ...

Eli Lilly and Co. Wednesday announced plans to ... Lilly expects to create 3,000 highly skilled manufacturing jobs for engineers, scientists, operations personnel and lab technicians along with ...